Interviews with participating patients from the VenoValve® U.S. Pivotal Trial ...

Consultant vascular surgeon Ian Nichol, who works at The James Cook University Hospital, saved the leg of Chris Dolan, 50 ...

MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...

VVeno Medical's NVNO submission of the final module for VenoValve’s Premarket Approval (PMA) application to the FDA represents a crucial milestone in addressing unmet needs in the treatment of Chronic ...

A new federal payment policy will sharply reduce the number of specialty wound care products available to certain Medicare patients.

Clinical Meaningful Benefit Responder Rate7.91 Point Average rVCSS Improvement for the Clinically Meaningful Benefit Responder Cohort75% ...

The Company is also developing a next-generation, non-surgical transcatheter based replacement venous valve called enVVe, which could appeal to an even larger market in terms of both patients and ...

The LCD covers skin substitute grafts/cellular and tissue-based products (CTP) for the treatment of diabetic foot ulcers (DFU) and venous leg ulcers (VLU) in the Medicare population and is now set to ...

Dublin, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The "Pressure Ulcers Treatment Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This pressure ulcers treatment market ...

(Nasdaq: MDXG) (“MIMEDX” or the “Company”) today provided the following update on the Local Coverage Determinations (“LCDs”) regarding “Skin Substitute Grafts/Cellular and Tissue-Based Products for ...

DARIEN, IL - A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects ...

A new clinical practice guideline developed by the American Academy of Sleep Medicine provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the ...